FLOW-CYTOMETRIC ANALYSIS OF DNA DISTRIBUTION AFTER VP16-213 TREATMENT OF LEWIS LUNG-CARCINOMA

被引：1
|
作者：
ERBA, E [1 ]
UBEZIO, P [1 ]
COLOMBO, T [1 ]
BROGGINI, M [1 ]
TORTI, L [1 ]
VAGHI, M [1 ]
DINCALCI, M [1 ]
MORASCA, L [1 ]
机构：
[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1983年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：208 / 211
页数：4
相关论文
共 50 条
  • [41] Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: I. Breast cancer
    Wimberger, P
    Hillemanns, P
    Kapsner, T
    Hepp, H
    Kimmig, R
    ANALYTICAL CELLULAR PATHOLOGY, 2002, 24 (4-5): : 135 - 145
  • [42] FLOW CYTOMETRIC ANALYSIS OF DNA CONTENT IN LUNG LAVAGE CELLS AFTER BLEOMYCIN INJURY
    MIGLIAZZO, A
    ROSENFIELD, C
    WESSELIUS, LJ
    CHEST, 1985, 88 : S29 - S29
  • [43] FLOW CYTOMETRIC ANALYSIS OF C-MYC ONCOPROTEIN IN NON-SMALL-CELL LUNG-CARCINOMA - COMPARISON WITH IMMUNOHISTOCHEMICAL RESULTS
    DESANTIS, L
    MANGILI, F
    SASSI, I
    DIROCCO, M
    ROSSI, C
    CANTABONI, A
    ANALYTICAL CELLULAR PATHOLOGY, 1995, 8 (03) : 247 - 257
  • [44] Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer
    Wimberger, P
    Hillemanns, P
    Kapsner, T
    Hepp, H
    Kimmig, R
    ANALYTICAL CELLULAR PATHOLOGY, 2002, 24 (4-5) : 147 - 158
  • [45] THE MULTIDRUG RESISTANT PHENOTYPE IN CLINICAL-PRACTICE - EVALUATION OF CROSS RESISTANCE TO IFOSFAMIDE AND MESNA AFTER VP16-213, DOXORUBICIN AND VINCRISTINE (VPAV) FOR SMALL CELL LUNG-CANCER
    CANTWELL, BMJ
    BOZZINO, JM
    CORRIS, P
    HARRIS, AL
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 123 - 129
  • [46] TREATMENT OF SMALL CELL ANAPLASTIC CARCINOMA OF LUNG WITH AN ORAL SOLUTION OF VP-16-213 (NSC-141540) - PHASE 2 TRIAL
    DOMBERNOWSKY, P
    HANSEN, HH
    NISSEN, NI
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 129 - 129
  • [47] FLOW CYTOMETRIC DNA CONTENT-ANALYSIS IN NEUROENDOCRINE CARCINOMA OF THE LUNG - CORRELATION WITH SURVIVAL AND HISTOLOGIC SUBTYPE
    JACKSONYORK, GL
    DAVIS, BH
    WARREN, WH
    GOULD, VE
    MEMOLI, VA
    CANCER, 1991, 68 (02) : 374 - 379
  • [48] CYTOXAN, ADRIAMYCIN, AND VINCRISTINE (CAV) VERSUS VP16-213+ CAV (VCAV) IN THE TREATMENT OF SMALL CELL-CARCINOMA OF THE LUNG (SCC)
    JACKSON, DV
    FERREE, C
    WHITE, DR
    RICHARDS, F
    MUSS, HB
    STUART, JJ
    COOPER, MR
    SPURR, CL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 393 - 393
  • [49] FLOW CYTOMETRIC ANALYSIS OF DNA PLOIDY AND CELL-CYCLE DISTRIBUTION OF PRIMARY LUNG-CANCER
    MORAN, RE
    MELAMED, MR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 8 - 8
  • [50] COMBINATION TREATMENT USING THYMOSIN ALPHA-1 AND INTERFERON AFTER CYCLOPHOSPHAMIDE IS ABLE TO CURE LEWIS LUNG-CARCINOMA IN MICE
    GARACI, E
    MASTINO, A
    PICA, F
    FAVALLI, C
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 32 (03) : 154 - 160
12345